CYTK
Cytokinetics Inc
Halal Rating :
Last Price
$45.78
Last updated:
Market Cap
-
7D Change
-1.99%
1 Year Change
-45.3%
Company Overview
Industries
Exchange
Next Earnings Date
Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised. The company's research and development activities are primarily directed toward the discovery and development of small molecule therapeutics that modulate muscle function.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $463000.0 | $163.56m | - | $22.3m | 0.00% | 13.63% |
| June 30, 2024 | $249000.0 | $154.72m | - | $24.3m | 0.00% | 15.71% |
| March 31, 2024 | $835000.0 | $144.39m | - | $17.32m | 0.00% | 12.00% |
Company Impact
Help us evaluate Cytokinetics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.